Aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder in a patient with Charcot-Marie-Tooth disease type 1A

Yuichi Hamada, Kazusa Takahashi, Takamichi Kanbayashi, Yuki Hatanaka, Shunsuke Kobayashi, Masahiro Sonoo

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with CMT1A who suffered from recurrent optic neuritis and myelopathy. Under the diagnosis of anti-aquaporin-4 (anti-AQP4) antibody positive neuromyelitis optica spectrum disorder (NMOSD), we treated her successfully with corticosteroids. This is the first report of CMT1A complicated with anti-AQP4-positive NMOSD. Although the coexistence of the two disorders may simply be a coincidence, we speculated that immune cross-reaction between overexpressed peripheral myelin protein 22 and CNS myelin may have caused concomitant CMT1A and NMOSD.

Original languageEnglish
Pages (from-to)1611-1614
Number of pages4
JournalInternal Medicine
Volume60
Issue number10
DOIs
StatePublished - 2021

Keywords

  • anti-aquaporin-4 antibody
  • Charcot-Marie-Tooth disease type 1A
  • Neuromyelitis optica spectrum disorder
  • Optic neuritis

Fingerprint

Dive into the research topics of 'Aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder in a patient with Charcot-Marie-Tooth disease type 1A'. Together they form a unique fingerprint.

Cite this